Small and mid cap

For years a few megacaps drove the market. In 2026 small caps are winning in every sector, and big tech's own spending is funding it

George Capozzi explains why alignment and durability matter more than hype when backing the next generation of small caps.

Sometimes the small fish, which are hardest to find, are the sweetest!

With markets at all time highs, one might think there is little value to be found. That's not the case in SMID-caps according to Qiao Ma.

LTR Pharma is a clinical-stage pharmaceutical company, commercialising a world first in erectile dysfunction, Spontan, a PDE5 nasal spray.

There is no denying they have been the ugly stepsister of share markets over the last 2-3 years. The chart above looks at U.S. listed companies' performance broken...

We have a high conviction view on gold and precious metals - a space where we see a compelling investment asymmetry to capitalise on.

Reporting season gives you opportunities on the buy side, but also to get out. The Maqro Research Team give you two of each from this season

Packed the car and ready to take a re-opening road trip? Enjoyed a responsible G&T during lockdown? If you have, you may be familiar with some of the brands I am...

Last year was a tough year for global earnings. The pandemic shook up global markets, with large earnings drawdowns across the world. In particular, global small and...